Sify News
www
Get Quote
NAVs
News
Follow us on
Portfolio Login
 
SENSEX
 
 
STOCKS LAST SEARCHED
   
IMAGEGALLERY
   
GOLD RATE
Rs. 28175.00
(10 gm)
Glitter Estimator
   
Get Company Quotes
Hot search: SBI, RIL, L&T, Infosys, ICICI Bank
Quote in alphabetical order:
 A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
 
 
Ranbaxy - Daiichi Sankyo Deal: Japanese company acquires stake in Indian firm
Daiichi Sankyo surprised the markets by buying out Ranbaxy's promoters. The Japanese pharmaceutical major has mega plans and reports suggest that the company is likely to set up a research and development centre in India. The sale has sent shockwaves among the Indian pharma companies as they fear the deal may trigger a spate of acquisitions in the near future.
More Specials
• RBI versus Sahara
• Mukesh mania
• Bonus bonanza
• Indian airports take wings
• Drooping rupee!
Bhai Mohan Singh Ranbaxy's milestones
In the early 1950s, Gurbax Singh, one of the original promoters of Ranbaxy sought additional financing and turned to a local moneylender, Bhai Mohan Singh. A glance through the turning points since then.
...................................................................................................................................................
Industry shocked
 Majors in the industry termed the Ranbaxy-Daiichi deal as `unexpected' and `dramatic'. When Ranbaxy said that its promoters were selling their entire stake to Daiichi Sankyo, it sent shockwaves throughout the industry.
...................................................................................................................................................
Malvinder Singh When predator turned prey
Ranbaxy, which was in the thick of its acquisitions strategy till recently, was even prowling around for a catch in the domestic market.
......................................................................................................................................................................................................................................
From Rs 2.5 lakh to Rs 9,576 cr
 From a meagre sum of Rs 2.5 lakh invested 56 years ago, Malvinder Mohan Singh will get Rs 9,576 crore, on behalf of his family, from the Japanese pharma major.
Fingers crossed
The future of a clutch of companies in which Ranbaxy has invested now hangs by a thread.
......................................................................................................................................................................................................................................